GSK, Moderna and Pfizer are all looking at potential respiratory syncytial virus vaccine sales slumps thanks to recently updated Centers for Disease Control and Prevention guidelines regarding the use of RSV shots in seniors. https://hubs.li/Q02JWLyB0 #pharma #RSV #biospace
BioSpace
Internet News
West Des Moines, Iowa 114,465 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis (Katz)
Head of Insights
Updates
-
BioSpace will continue to be your source of news on job cuts and restructuring initiatives throughout 2024. Follow along as we keep you up to date on which companies are tightening their belts and cutting staff. https://hubs.li/Q02JTb3r0 #biopharma #layoffs #biospace
Biopharma Layoff Tracker 2024: uniQure, Vir, Arbutus and More Cut Staff
biospace.com
-
Approved under the regulator’s accelerated pathway, Tecelra is also the first new synovial sarcoma therapy in more than a decade, according to Adaptimmune. https://hubs.li/Q02JTcYf0 #pharma #biospace
Adaptimmune’s Tecelra Becomes First FDA-Approved Engineered Cell Therapy for Solid Tumors
biospace.com
-
In pursuit of Merck's blockbuster Keytruda, GSK's Jemperli scored its own broad FDA label expansion, allowing its use in the first-line endometrial cancer regardless of biomarker status. https://hubs.li/Q02JSzvn0 #pharma #regulatory #oncology #biospace
GSK Wins Broad Label Expansion for Jemperli in First-Line Endometrial Cancer
biospace.com
-
As part of a major reorganization, Vir Biotechnology, Inc. has discontinued the bulk of its virology work and pivoted to cancer in an exclusive licensing deal with Sanofi. https://hubs.li/Q02JSrMD0 #pharma #oncology #biospace
Vir Lays Off 25% of Staff, Abandons Most Virus Work and Pivots to Cancer in Sanofi Deal
biospace.com
-
Poor efficacy data for two early-stage candidates for the rare disease alpha-1 antitrypsin deficiency have convinced Vertex Pharmaceuticals to terminate their development. https://hubs.li/Q02JSnck0 #pharma #biospace
Vertex Scraps Two Phase I AATD Candidates Following Disappointing Data
biospace.com
-
Discover the latest updates in BioSpace's Bipharma Layoff Tracker 2024, as Arbutus Biopharma Corporation, HilleVax, Bayer and more reduce their workforce. https://hubs.ly/Q02JPyXn0 #layoffs #pharma #biotech #biospace
Biopharma Layoff Tracker 2024: Arbutus, HilleVax, Bayer and More Cut Staff
biospace.com
-
Moderna's stock price plunged more than 20% in Thursday morning trading after the company lowered its 2024 revenue guidance due to weak demand for its coronavirus vaccine in the second quarter. https://hubs.ly/Q02JPvgK0 #pharma #finance #biospace
Moderna Cuts Full-Year Revenue Guidance as COVID-19 Vaccine Sales Crater in Q2
biospace.com
-
With an upfront $800 million payment and $325 million in potential milestones, Otsuka Pharmaceutical Companies (U.S.) is acquiring Jnana Therapeutics' drug discovery platform and rare disease candidate, the companies announced Thursday. https://hubs.ly/Q02JPw-N0 #pharma #finance #biospace
Otsuka Pays Up to $1.1B to Buy Jnana, Adds Drug Discovery Capabilities
biospace.com
-
Eli Lilly and Company on Thursday released late-stage data showing a 38% reduction in the risk of heart failure outcomes, as it plays catch-up with Novo Nordisk's semaglutide which won the FDA's cardio nod in March. https://hubs.li/Q02JKNk50 #pharma #GLP1 #biospace
Lilly’s Tirzepatide Clears Phase III Cardiovascular Study on Heels of Novo
biospace.com